Tuesday, April 30, 2019
The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Facebook (FB), Comcast (CMCSA) and AbbVie (ABBV). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.
You can see all of today’s research reports here >>>
Buy-ranked Facebook’s shares have gained +48.6% year to date, outperforming the S&P 500’s increase of +17.1% during the same period. Facebook reported impressive first-quarter 2019 results, driven by solid mobile ad revenues that benefited from impression growth on both Instagram Stories and Feed, and Facebook News Feed.
Asia-Pacific remained the company’s fastest growing market, driven by user growth in India, Indonesia and the Philippines. The Zacks analyst thinks that although focus on security will likely negatively impact some advertisers’ ability to run legitimate ads on the platform, Stories are increasingly becoming an important growth opportunity for advertisers.
Interactive Stories Ads on Instagram are expected to improve interaction among people, businesses and advertisers. Further, the Checkout feature on Instagram is part of Facebook’s e-commerce endeavors. However, continued mix shift toward Stories is expected to hurt ARPU. Increasing regulatory headwinds are also a concern.
(You can read the full research report on Facebook here >>>).
Shares of Buy-ranked Comcast have outperformed the Zacks Cable Television industry in the past year, gaining +35.5% vs. +23%. Comcast’s first-quarter 2019 results benefited from solid growth in the number of residential high-speed Internet customers.
The Zacks analyst thinks the company’s strategy to market broadband-only packages to customers is benefiting top-line growth. Further, expanding Wi-Fi coverage along with innovative xFi control features is improving customer experience.
The company’s Xfinity Mobile is now used by more than one million customers. Wireless revenues also grew strongly in the quarter, driven by expanding customer base. Further, the Sky acquisition expanded Comcast’s international reach. Sky’s content strength is a major growth driver. However, the company continues to lose voice and video subscribers due to cord-cutting and stiff competition. Additionally, its high debt level is a headwind.
(You can read the full research report on Comcast here >>>).
Buy-ranked AbbVie’s shares have gained +3.1% in the past six months, outperforming the Zacks Large-Cap Pharmaceuticals industry's decline of -0.4%. AbbVie beat estimates for both earnings and sales in the first quarter. The Zacks analyst thinks AbbVie’s key drug, Humira is seeing robust growth in the United States based on strong demand trends despite new competition.
Moreover, Imbruvica has multibillion dollar potential. Mavyret has become a significant contributor to sales in a short time on the market. AbbVie has also been successful in expanding approvals for its cancer drugs, Imbruvica and Venclexta.
AbbVie has an impressive late-stage pipeline comprising several products with multibillion-dollar potential expected to be launched in the near term. Sales erosion due to direct biosimilar competition to Humira in international markets will be a big headwind in 2019. Also, costs to support expected new product/line extension launches should hurt profits in 2019.
(You can read the full research report on AbbVie here >>>).
Other noteworthy reports we are featuring today include Union Pacific (UNP), ServiceNow (NOW) and Air Products (APD).
Is Your Investment Advisor Fumbling Your Financial Future?
See how you can more effectively safeguard your retirement with a new Special Report, “4 Warning Signs Your Investment Advisor Might Be Sabotaging Your Financial Future.”
Click to get it free >>
Note: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>>
Today's Must Read
Mobile Ad Growth, Stories Adoption Benefits Facebook (FB)
High Speed Internet Subscriber Gains Benefit Comcast (CMCSA)
AbbVie's (ABBV) Humira U.S. Sales Strong, Pipeline Solid
Dividends & Buybacks Buoy Union Pacific (UNP) Amid Debt Woes
The Zacks analyst likes the company's efforts to reward shareholders. However, its high debt levels are a concern.
Project Investments, Productivity to Aid Air Products (APD)
While Air Products faces unfavorable currency swings, it will gain from investments in high-return projects and productivity improvement initiatives, per the Zacks analyst.
TD Ameritrade (AMTD) Records Rise in DARTs, High Costs A Woe
The Zacks analyst thinks TD Ameritrade is will grow through improving trading activities as DARTs continued to rise.
VeriSign (VRSN) Rides on Higher Domain Name Registrations
The Zacks analyst is encouraged by the increase in domain name base, renewal of the .com contract and price hikes for the .com and .net domain names.
Strong Execution of Syncrude Project Aids Imperial Oil (IMO)
Per the Zacks analyst, strong execution and ramped-up activities in Kearl, Cold Lake and Syncrude projects position Imperial Oil well for solid production growth and FCFs.
Business Restructuring, Asset Growth Aid Ameriprise (AMP)
Per the Zacks analyst, Ameriprise is well positioned for top-line growth through rise in assets under management, restructuring/streamlining initiatives and efforts to modify product offerings.
Hess (HES) Grows on Strong Bakken & GoM Oil Output Volumes
The Zacks analyst believes that robust oil production from onshore Bakken play and offshore resources in the Gulf of Mexico will enable Hess to generate huge profit in the coming quarters.
Growing Customer Base & Partnerships Aid ServiceNow (NOW)
Per the Zacks analyst, ServiceNow benefits from expanding Global 2000 (G2K) customer base undergoing digital transformation. Further, strategic alliances with the likes of Microsoft are a tailwind.
New Vehicles, Robust Demand in North America Drive Ford (F)
Per the Zacks analyst, strong demand for F-series trucks and utilities in the United States is driving Ford's sales volumes. Also, the introduction of advanced vehicles is aiding its top line.
Solid Balance Sheet, Strong U.S. Business Aids Aflac (AFL)
Per the Zacks analyst, Aflac U.S. continues to perform strongly and has boosted top-line growth. Its strong balance sheet enables share buyback & dividend payment and higher investment in business.
Petrobras (PBR) Weighed Down By Massive Debt Load
The Zacks analyst is worried over Petrobras' net debt of roughly $70 billion, which has left the company two notches below an investment grade rating.
Price Woes, Weak Margins Impede Intersect ENT's (XENT) Growth
The pricing scenario is tough for Intersect ENT due to cost sensitivities. The Zacks analyst is also concerned about escalating expenses putting pressure on the bottom line.
Perrigo (PRGO) Faces Pricing Pressure, Stiff Competition
Per the Zacks analyst, Perrigo's revenues continue to be unfavourably impacted by pricing and other macro-economic pressures.
Union Pacific Corporation (UNP) : Free Stock Analysis Report
ServiceNow, Inc. (NOW) : Free Stock Analysis Report
Facebook, Inc. (FB) : Free Stock Analysis Report
Comcast Corporation (CMCSA) : Free Stock Analysis Report
Air Products and Chemicals, Inc. (APD) : Free Stock Analysis Report
AbbVie Inc. (ABBV) : Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research